rs547831370
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_002691.4(POLD1):c.1745C>T(p.Thr582Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,610,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T582A) has been classified as Uncertain significance.
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.1745C>T | p.Thr582Met | missense_variant | 14/27 | ENST00000440232.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POLD1 | ENST00000440232.7 | c.1745C>T | p.Thr582Met | missense_variant | 14/27 | 1 | NM_002691.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000592 AC: 9AN: 152000Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000244 AC: 6AN: 245544Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133386
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1458390Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 725176
GnomAD4 genome ? AF: 0.0000592 AC: 9AN: 152000Hom.: 0 Cov.: 30 AF XY: 0.0000539 AC XY: 4AN XY: 74232
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 05, 2017 | This variant is denoted POLD1 c.1745C>T at the cDNA level, p.Thr582Met (T582M) at the protein level, and results in the change of a Threonine to a Methionine (ACG>ATG). This variant has been reported a pediatric patient with B-lineage acute lymphoblastic leukemia (Zhang 2015). POLD1 Thr582Met was not observed at a significant allele frequency in large population cohorts (Lek 2016). Since Threonine and Methionine differ in polarity, charge, size or other properties, this is considered a non-conservative amino acid substitution. POLD1 Thr582Met is located in the polymerase domain (Preston 2010). In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Based on currently available evidence, it is unclear whether POLD1 Thr582Met is pathogenic or benign. We consider it to be a variant of uncertain significance. - |
Colorectal cancer, susceptibility to, 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jan 12, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 582 of the POLD1 protein (p.Thr582Met). This variant is present in population databases (rs547831370, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with POLD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 408117). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POLD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at